← back to search

Luis Isola

Icahn School of Medicine at Mount Sinai · US
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, and Chronic Myeloid Leukemia Treatments.
h-index
45
citations
8,210
works
196
NIH funding
primary concept
Medicine
email

Recent publications

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report
Blood Advances 2020cited by 34position: middledoi
Multiple Myeloma Cost of Care Under the Oncology Care Model: The Influence of High-Cost Therapies.
2020cited by 9position: contributordoi
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial
The Lancet Haematology 2017cited by 168position: middledoi
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis
Blood 2014cited by 149position: middledoi
Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation
Blood 2014cited by 37position: middledoi
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
New England Journal of Medicine 2012cited by 1,140position: middledoi
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Blood 2012cited by 137position: middledoi
Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis
Biology of Blood and Marrow Transplantation 2012cited by 10position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Robert S. Hoffman · Fraunhofer Institute for Ceramic Technologies and Systems2 papers (2012–2014)Meir Wetzler · University of Colorado Denver2 papers (2012–2014)Josef T. Prchal · Huntsman Cancer Institute2 papers (2012–2014)Vesna Najfeld · Rockefeller University2 papers (2012–2014)Hillard M. Lazarus · Case Western Reserve University2 papers (2012–2014)Alessandro M. Vannucchi · All India Institute of Medical Sciences2 papers (2012–2014) · 2 papers (2012–2014)Alessandro Rambaldi · Astellas Pharma (United States)2 papers (2012–2014) · 2 papers (2012–2014)Tsiporah B. Shore · Cornell University2 papers (2012–2014)Leah Price · New York University2 papers (2012–2014)Andrea Bacigalupo · Advanced Radiation Therapy (United States)2 papers (2012–2014) · 2 papers (2012–2014) · 2 papers (2012–2014)Judith D. Goldberg · NYU Langone Health2 papers (2012–2014)Damiano Rondelli · University of Illinois Chicago2 papers (2012–2014)Rebecca B. Klisovic · University Hospitals Seidman Cancer Center2 papers (2012–2014)Parameswaran Hari · Medical College of Wisconsin1 papers (2012–2012)Vincent T. Ho · Harvard Stem Cell Institute1 papers (2014–2014)Harry C. Schouten · Medical College of Wisconsin1 papers (2012–2012)